Difference between revisions of "FNSGp"
From Bioblast
(Created page with "{{MitoPedia |abbr=FNSGp |description='''FNSGp''': Octanoylcarnitine or Palmitoylcarnitine & Pyruvate &/or Glutamate & Malate & Succinate & Glyceropho...") |
|||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{MitoPedia | {{MitoPedia | ||
|abbr=FNSGp | |abbr=FNSGp | ||
|description= | |description=[[Image:SUIT-catg_FNSGp.jpg|right|400px|Convergent electron flow]] | ||
'''MitoPathway control state:''' FNSGp | '''MitoPathway control state:''' FNSGp | ||
:[[Octanoylcarnitine]] or [[Palmitoylcarnitine]] & [[Pyruvate]] &/or [[Glutamate]] & [[Malate]] & [[Succinate]] & [[Glycerophosphate]]. | |||
'''SUIT protocol:''' [[SUIT-002]] | '''SUIT protocol:''' [[SUIT-002]] | ||
| Line 9: | Line 10: | ||
This substrate combination supports convergent electron flow to the [[Q-junction]]. | This substrate combination supports convergent electron flow to the [[Q-junction]]. | ||
|info=[[MiPNet21.06 SUIT reference protocol]] | |info=[[MiPNet21.06 SUIT reference protocol]], [[Gnaiger 2020 BEC MitoPathways]] | ||
}} | }} | ||
::: ''More details'' | |||
::::» [[Additive effect of convergent electron flow]] | |||
::::» [[Respiratory_complexes#Respiratory_complexes_-_more_than_five |Respiratory complexes - more than five]] | |||
::::» [[OctPGMSGp pathway control state]] | |||
::::» [[Convergent electron flow]] | |||
== FNSGp | == FNSGp<sub>''L''</sub> == | ||
FNSGp pathway in the LEAK state can be evaluated in the following SUIT protocols: | |||
== FNSGp | == FNSGp<sub>''P''</sub>== | ||
:::[[SUIT-002]] | FNSGp pathway in the OXPHOS state can be evaluated in the following SUIT protocols: | ||
:::[[SUIT-002 O2 mt D005]] | :::*[[SUIT-002]] | ||
:::[[SUIT-002 O2 pfi D006]] | ::::* DL-Protocol for isolated mitochondria and tissue homogenate (mt): [[SUIT-002 O2 mt D005]] | ||
:::[[SUIT-002 O2 pce D007]] | ::::* DL-Protocol for permeabilized fibers (pfi): [[SUIT-002 O2 pfi D006]] | ||
::::* DL-Protocol for permeabilized cells (pce): [[SUIT-002 O2 ce-pce D007]] | |||
== FNSGp | == FNSGp<sub>''E''</sub>== | ||
:::[[SUIT-002]] | FNSGp pathway in the ET state can be evaluated in the following SUIT protocols: | ||
:::[[SUIT-002 O2 mt D005]] | :::*[[SUIT-002]] | ||
:::[[SUIT-002 O2 pfi D006]] | ::::* DL-Protocol for isolated mitochondria and tissue homogenate (mt): [[SUIT-002 O2 mt D005]] | ||
:::[[SUIT-002 O2 pce D007]] | ::::* DL-Protocol for permeabilized fibers (pfi): [[SUIT-002 O2 pfi D006]] | ||
::::* DL-Protocol for permeabilized cells (pce): [[SUIT-002 O2 ce-pce D007]] | |||
| Line 35: | Line 40: | ||
[[File:SUIT-Reference-Protocol 2.jpg|700px |SUIT RP2]] | [[File:SUIT-Reference-Protocol 2.jpg|700px |SUIT RP2]] | ||
---- | ---- | ||
{{MitoPedia concepts | |||
|mitopedia concept=SUIT state | |||
}} | |||
Revision as of 19:57, 1 January 2021
- high-resolution terminology - matching measurements at high-resolution
FNSGp
Description
MitoPathway control state: FNSGp
- Octanoylcarnitine or Palmitoylcarnitine & Pyruvate &/or Glutamate & Malate & Succinate & Glycerophosphate.
SUIT protocol: SUIT-002
This substrate combination supports convergent electron flow to the Q-junction.
Abbreviation: FNSGp
Reference: MiPNet21.06 SUIT reference protocol, Gnaiger 2020 BEC MitoPathways
FNSGpL
FNSGp pathway in the LEAK state can be evaluated in the following SUIT protocols:
FNSGpP
FNSGp pathway in the OXPHOS state can be evaluated in the following SUIT protocols:
-
- DL-Protocol for isolated mitochondria and tissue homogenate (mt): SUIT-002 O2 mt D005
- DL-Protocol for permeabilized fibers (pfi): SUIT-002 O2 pfi D006
- DL-Protocol for permeabilized cells (pce): SUIT-002 O2 ce-pce D007
-
FNSGpE
FNSGp pathway in the ET state can be evaluated in the following SUIT protocols:
-
- DL-Protocol for isolated mitochondria and tissue homogenate (mt): SUIT-002 O2 mt D005
- DL-Protocol for permeabilized fibers (pfi): SUIT-002 O2 pfi D006
- DL-Protocol for permeabilized cells (pce): SUIT-002 O2 ce-pce D007
-
MitoPedia concepts:
SUIT state
